NCT07561814 A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
| NCT ID | NCT07561814 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Zhongshan Hospital |
| Condition | Pancreatic Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,030 participants |
| Start Date | 2025-12-09 |
| Primary Completion | 2029-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,030 participants in total. It began in 2025-12-09 with a primary completion date of 2029-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn if combining information from CT scans, blood tests, and pathology reports can better predict how pancreatic cancer will progress. The main questions it aims to answer are: * Can combining these types of data more accurately estimate how long a person might survive? * Can it better predict the risk of recurrence? Participants will not have any extra tests or treatments. They will: * Allow researchers to collect information from their existing medical records (such as surgery reports, imaging, and lab results) * Receive a follow-up phone call for up to 3 years to share health updates（about every 3 months for the prospective cohort）.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years. * Histologically or cytologically confirmed diagnosis of pancreatic cancer. * Availability of preoperative and postoperative contrast-enhanced CT images at the participating center; patient records include corresponding clinical data, postoperative pathological reports, and preoperative and postoperative blood test results. * Underwent surgical treatment for pancreatic cancer at a participating center of this study. Exclusion Criteria: * Age \< 18 years (minors). * Presence of other severe diseases (e.g., severe liver or kidney failure, cardiovascular or cerebrovascular diseases, malignancies other than pancreatic cancer); pregnant or breastfeeding women; individuals with mental illness; * patients unable to comply with follow-up or provide informed consent. * Presence of significant outliers (e.g., laboratory values exceeding 10 times the normal range without clinically reasonable explanation) or samples with excessive missing data.
Frequently Asked Questions
Who can join the NCT07561814 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07561814 currently recruiting?
Yes, NCT07561814 is actively recruiting participants. Visit ClinicalTrials.gov or contact Shanghai Zhongshan Hospital to inquire about joining.
Where is the NCT07561814 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07561814 clinical trial?
NCT07561814 is sponsored by Shanghai Zhongshan Hospital. The trial plans to enroll 1,030 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.